➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
McKesson
Johnson and Johnson
Express Scripts

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Patent: 10,202,357

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,202,357
Title:Class of quinolone heterocyclic aromatic molecules for cancer treatment
Abstract: The invention is directed to new class of quinolone heterocyclic aromatic molecules (Renotinibs) and their use in the treatment of cancer, in particular, cancer that harbor abnormal human epidermal growth factor receptors (EGFRs).
Inventor(s): Wang; Jujun (Plano, TX), Tsao; Allen (Wind Lake, WI), Liu; Xiaomei (Flushing, NY)
Assignee: RenoTarget Therapeutics, Inc. (Wind Lake, WI)
Application Number:15/803,478
Patent Claims:see list of patent claims

Details for Patent 10,202,357

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial RenoTarget Therapeutics, Inc. (Wind Lake, WI) 2036-11-09 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial RenoTarget Therapeutics, Inc. (Wind Lake, WI) 2036-11-09 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial RenoTarget Therapeutics, Inc. (Wind Lake, WI) 2036-11-09 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial RenoTarget Therapeutics, Inc. (Wind Lake, WI) 2036-11-09 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Moodys
AstraZeneca
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.